Free Eye Drops Distribution To Mitigate Drug Side Effects Cleared By HHS OIG

Program relies on a third-party vendor managing a Risk Evaluation and Mitigation Strategy associated with the drug to facilitate delivery of eye drops to patients.

Program Would Not Trigger Kickback Concerns, OIG Concludes • Source: Alamy

More from Compliance

More from Pink Sheet